Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, this German development bank appears to focus on early-stage investments across diverse sectors including biotech, cleantech, and enterprise software, with a particular emphasis on deep-tech and life sciences applications. Recent portfolio companies suggest an interest in transformative technologies spanning mRNA therapeutics, quantum computing, and SaaS solutions, deployed through check sizes ranging from €0.1M to €1.5M at pre-seed and seed stages.
Generated 10 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.